SCHEMBL1614566

SCHEMBL1614566

CCCCCCCCCCCCCCCCCc1cccc(O)c1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BID P55957 3/20 0.63
MCL1 Q07820 3/20 0.63
IAPP P10997 3/20 0.63
BCL2L1 Q07817 2/20 0.63
BAK1 Q16611 2/20 0.63
KAT8 Q9H7Z6 2/20 0.63
SAE1 Q9UBE0 2/20 0.63
PPARG P37231 1/20 0.63
PPARA Q07869 1/20 0.63
EP300 Q09472 1/20 0.63
KAT2A Q92830 1/20 0.63
KAT2B Q92831 1/20 0.63
KAT5 Q92993 1/20 0.63
ALOX5 P09917 2/20 0.62
PTGS2 P35354 1/20 0.62
TYR P14679 2/20 0.61
ELANE P08246 2/20 0.56
CTSG P08311 2/20 0.56
LIPG Q9Y5X9 1/20 0.55
MMP2 P08253 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1481822 1.00 BID (0.63) BIDMCL1IAPPBCL2L1BAK1
SCHEMBL9739269 1.00 BID (0.63) BIDMCL1IAPPBCL2L1BAK1
SCHEMBL5320034 1.00 BID (0.63) BIDMCL1IAPPBCL2L1BAK1
SCHEMBL5586819 1.00 BID (0.63) BIDMCL1IAPPBCL2L1BAK1
SCHEMBL6471772 1.00 BID (0.63) BIDMCL1IAPPBCL2L1BAK1
SCHEMBL11041823 1.00 BID (0.63) BIDMCL1IAPPBCL2L1BAK1
SCHEMBL11684136 1.00 BID (0.63) BIDMCL1IAPPBCL2L1BAK1
SCHEMBL1207097 1.00 BID (0.63) BIDMCL1IAPPBCL2L1BAK1
SCHEMBL9188752 1.00 BID (0.63) BIDMCL1IAPPBCL2L1BAK1
SCHEMBL30468322 1.00 BID (0.63) BIDMCL1IAPPBCL2L1BAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326910-A1 METHOD FOR PRODUCING SURFACE-MODIFIED MICRO-FIBRILLATED CELLULOSE DÄTWYLER SCHWEIZ AG (CH) 2025-10-23 US claimed
EP-4532567-A1 METHOD FOR PRODUCING SURFACE-MODIFIED MICRO-FIBRILLATED CELLULOSE Dätwyler Schweiz AG (CH) 2025-04-09 EP claimed
EP-3274322-B1 STABLE COMPOSITIONS FOR PREVENTION / PROPHYLACTIC TREATMENT OF POISON IVY DERMATITIS THE UNIV OF MISSISSIPPI (US) 2024-08-14 EP claimed
WO-2023225764-A1 METHOD FOR PRODUCING SURFACE-MODIFIED MICRO-FIBRILLATED CELLULOSE DÄTWYLER SCHWEIZ AG (CH) 2023-11-30 WO claimed
US-11666667-B2 Patches comprising urushiol, test panels comprising the same, and methods of using the same HAPTEN SCIENCES, INC. (US) 2023-06-06 US claimed
US-20150004161-A1 Fc Coupled Compositions and Methods of Their Use NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2015-01-01 US claimed
CN-101609725-B Nano conductive extract SHANGHAI GUANGTUO CONDUCTIVE MATERIAL TECHNOLOGY CO LTD 2011-02-02 CN claimed
CN-101609725-A Nano conductive extract YOULIANG CHENG (CN) 2009-12-23 CN claimed
US-20060147341-A1 Article and method for detecting skin irritants JAHNGEN EDWIN G 2006-07-06 US claimed
US-4428965-A Tolerizing and desensitizing compounds, compositions and methods of treatment against dermatological conditions caused by allergens from plants and trees of the Anacardiaceae and Ginkgoaceae families THE UNIVERSITY OF MISSISSIPPI (US) 1984-01-31 US claimed
EP-4721580-A1 METHOD FOR PRODUCING ALDEHYDE COMPOUND AND APPLICATION THEREOF Amano Enzyme Inc. (JP) 2026-04-08 EP disclosed
US-20260055238-A1 RESIN COMPOSITION FOR SEALING STATOR AND METHOD FOR DISASSEMBLING STATOR SUMITOMO BAKELITE CO., LTD. (JP) 2026-02-26 US disclosed
US-12534852-B2 Ink composition for ink jet textile printing and recording method SEIKO EPSON CORPORATION (JP) 2026-01-27 US disclosed
US-12486415-B2 Ink jet textile-printing ink composition, recording method, and recorded material SEIKO EPSON CORPORATION (JP) 2025-12-02 US disclosed
US-20250326910-A1 METHOD FOR PRODUCING SURFACE-MODIFIED MICRO-FIBRILLATED CELLULOSE DÄTWYLER SCHWEIZ AG (CH) 2025-10-23 US disclosed
WO-1998000439-A9 MULTIVALENT COMPOUNDS FOR CROSS-LINKING RECEPTORS AND USES THEREOF 1998-05-07 WO disclosed
WO-1998000439-A2 MULTIVALENT COMPOUNDS FOR CROSS-LINKING RECEPTORS AND USES THEREOF TRUSTEES OF TUFTS COLLEGE (US) 1998-01-08 WO disclosed
EP-0805628-A1 RECEPTOR SPECIFIC TRANSEPITHELIAL TRANSPORT OF IMMUNOGENS BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 1997-11-12 EP disclosed
WO-1996022024-A1 RECEPTOR SPECIFIC TRANSEPITHELIAL TRANSPORT OF IMMUNOGENS BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 1996-07-25 WO disclosed
US-4428965-A Tolerizing and desensitizing compounds, compositions and methods of treatment against dermatological conditions caused by allergens from plants and trees of the Anacardiaceae and Ginkgoaceae families THE UNIVERSITY OF MISSISSIPPI (US) 1984-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534852-B2 Ink composition for ink jet textile printing and recording method IL4, WIZ, TCF12 BID 4205/4885MCL1 1626/4885IAPP 2164/4885
US-20260055238-A1 RESIN COMPOSITION FOR SEALING STATOR AND METHOD FOR DISASSEMBLING STATOR RAD51, RCOR1, SEM1 BID 3243/4885MCL1 2657/4885IAPP 4636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.